79 related articles for article (PubMed ID: 27346399)
1. [Regulatory effect and mechanism of RNA binding motif protein 38 on the expression of progesterone receptor in human breast cancer ZR-75-1 cells].
Lou PP; Li CL; Xia TS; Shi L; Wu J; Zhou XJ; Wang Y; Ding Q
Zhonghua Zhong Liu Za Zhi; 2016 Jun; 38(6):425-9. PubMed ID: 27346399
[TBL] [Abstract][Full Text] [Related]
2. RNPC1 enhances progesterone receptor functions by regulating its mRNA stability in breast cancer.
Lou P; Li C; Shi L; Xia TS; Zhou W; Wu J; Zhou X; Li X; Wang Y; Wei JF; Ding Q
Oncotarget; 2017 Mar; 8(10):16387-16400. PubMed ID: 27634883
[TBL] [Abstract][Full Text] [Related]
3. [RNPC1 induces sensitivity of HER-2-positive breast cancer BT474 cells to trastuzumab through upregulation of HER2].
Li CL; Zhou XJ; Lou PP; Xia TS; Shi L; Wang Y; Ding Q
Zhonghua Zhong Liu Za Zhi; 2016 Mar; 38(3):172-8. PubMed ID: 26988821
[TBL] [Abstract][Full Text] [Related]
4. RNA-binding protein RNPC1: acting as a tumor suppressor in breast cancer.
Xue JQ; Xia TS; Liang XQ; Zhou W; Cheng L; Shi L; Wang Y; Ding Q
BMC Cancer; 2014 May; 14():322. PubMed ID: 24884756
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor (ER) was regulated by RNPC1 stabilizing mRNA in ER positive breast cancer.
Shi L; Xia TS; Wei XL; Zhou W; Xue J; Cheng L; Lou P; Li C; Wang Y; Wei JF; Ding Q
Oncotarget; 2015 May; 6(14):12264-78. PubMed ID: 25881544
[TBL] [Abstract][Full Text] [Related]
6. RNPC1, an RNA-binding protein and a target of the p53 family, regulates p63 expression through mRNA stability.
Zhang J; Jun Cho S; Chen X
Proc Natl Acad Sci U S A; 2010 May; 107(21):9614-9. PubMed ID: 20457941
[TBL] [Abstract][Full Text] [Related]
7. RNA Binding Protein RNPC1 Inhibits Breast Cancer Cell Metastasis via Activating STARD13-Correlated ceRNA Network.
Zheng L; Zhang Z; Zhang S; Guo Q; Zhang F; Gao L; Ni H; Guo X; Xiang C; Xi T
Mol Pharm; 2018 Jun; 15(6):2123-2132. PubMed ID: 29733656
[TBL] [Abstract][Full Text] [Related]
8. MDM2 expression is repressed by the RNA-binding protein RNPC1 via mRNA stability.
Xu E; Zhang J; Chen X
Oncogene; 2013 Apr; 32(17):2169-78. PubMed ID: 22710720
[TBL] [Abstract][Full Text] [Related]
9. PTEN expression is upregulated by a RNA-binding protein RBM38 via enhancing its mRNA stability in breast cancer.
Zhou XJ; Wu J; Shi L; Li XX; Zhu L; Sun X; Qian JY; Wang Y; Wei JF; Ding Q
J Exp Clin Cancer Res; 2017 Oct; 36(1):149. PubMed ID: 29052531
[TBL] [Abstract][Full Text] [Related]
10. Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells.
Chang HL; Sugimoto Y; Liu S; Ye W; Wang LS; Huang YW; Lin YC
Anticancer Res; 2006; 26(3A):1773-84. PubMed ID: 16827106
[TBL] [Abstract][Full Text] [Related]
11. RNA-binding protein RNPC1 acts as an oncogene in gastric cancer by stabilizing aurora kinase B mRNA.
Ji CM; Zhang X; Fang W; Meng L; Wei X; Lu C
Exp Cell Res; 2021 Sep; 406(1):112741. PubMed ID: 34302858
[TBL] [Abstract][Full Text] [Related]
12. RNA Binding Protein RNPC1 Suppresses the Stemness of Human Endometrial Cancer Cells via Stabilizing MST1/2 mRNA.
Wu X; Wang Y; Zhong W; Cheng H; Tian Z
Med Sci Monit; 2020 Feb; 26():e921389. PubMed ID: 32088727
[TBL] [Abstract][Full Text] [Related]
13. RNPC1, an RNA-binding protein and a p53 target, regulates macrophage inhibitory cytokine-1 (MIC-1) expression through mRNA stability.
Yin T; Cho SJ; Chen X
J Biol Chem; 2013 Aug; 288(33):23680-6. PubMed ID: 23836903
[TBL] [Abstract][Full Text] [Related]
14. The RNA-binding protein RNPC1 stabilizes the mRNA encoding the RNA-binding protein HuR and cooperates with HuR to suppress cell proliferation.
Cho SJ; Jung YS; Zhang J; Chen X
J Biol Chem; 2012 Apr; 287(18):14535-44. PubMed ID: 22371495
[TBL] [Abstract][Full Text] [Related]
15. Progestin inhibition of progesterone receptor gene expression in human breast cancer cells.
Alexander IE; Clarke CL; Shine J; Sutherland RL
Mol Endocrinol; 1989 Sep; 3(9):1377-86. PubMed ID: 2608065
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA regulation of progesterone receptor in breast cancer.
Gilam A; Shai A; Ashkenazi I; Sarid LA; Drobot A; Bickel A; Shomron N
Oncotarget; 2017 Apr; 8(16):25963-25976. PubMed ID: 28404930
[TBL] [Abstract][Full Text] [Related]
17. The unique transcriptional response produced by concurrent estrogen and progesterone treatment in breast cancer cells results in upregulation of growth factor pathways and switching from a Luminal A to a Basal-like subtype.
Need EF; Selth LA; Trotta AP; Leach DA; Giorgio L; O'Loughlin MA; Smith E; Gill PG; Ingman WV; Graham JD; Buchanan G
BMC Cancer; 2015 Oct; 15():791. PubMed ID: 26498662
[TBL] [Abstract][Full Text] [Related]
18. TReP-132 is a novel progesterone receptor coactivator required for the inhibition of breast cancer cell growth and enhancement of differentiation by progesterone.
Gizard F; Robillard R; Gross B; Barbier O; Révillion F; Peyrat JP; Torpier G; Hum DW; Staels B
Mol Cell Biol; 2006 Oct; 26(20):7632-44. PubMed ID: 17015480
[TBL] [Abstract][Full Text] [Related]
19. Radiation sensitivity of esophageal adenocarcinoma: the contribution of the RNA-binding protein RNPC1 and p21-mediated cell cycle arrest to radioresistance.
Hötte GJ; Linam-Lennon N; Reynolds JV; Maher SG
Radiat Res; 2012 Mar; 177(3):272-9. PubMed ID: 22214381
[TBL] [Abstract][Full Text] [Related]
20. Progesterone receptor activation downregulates GATA3 by transcriptional repression and increased protein turnover promoting breast tumor growth.
Izzo F; Mercogliano F; Venturutti L; Tkach M; Inurrigarro G; Schillaci R; Cerchietti L; Elizalde PV; Proietti CJ
Breast Cancer Res; 2014 Dec; 16(6):491. PubMed ID: 25479686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
